Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Magirr

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|February 14, 2012
Block response-adaptive randomization in clinical trials with binary endpointsDominic Magirr
Pharmaceutical Statistics|December 22, 2020
Non-proportional hazards in immuno-oncology: Is an old perspective needed?Dominic Magirr
Pharmaceutical Statistics|December 18, 2025
Robust Modestly Weighted Log-Rank TestsDominic Magirr, Fredrik Öhrn
Biometrical Journal. Biometrische Zeitschrift|February 3, 2023
Stratified modestly weighted log-rank tests in settings with an anticipated delayed separation of survival curvesDominic Magirr, José L Jiménez
JAMA Oncology|February 9, 2023
The MaxCombo Test Severely Violates the Type I Error RateDominic Magirr, Carl-Fredrik Burman
Statistics in Medicine|May 28, 2019
Modestly weighted logrank testsDominic Magirr, Carl-Fredrik Burman
Clinical Trials (London, England)|March 8, 2022
Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidanceDominic Magirr, José L Jiménez
Statistics in Medicine|December 24, 2015
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labelsMagdalena Żebrowska, Martin Posch, Dominic Magirr
Statistical Methods in Medical Research|December 18, 2012
Some recommendations for multi-arm multi-stage trialsJames Wason, Dominic Magirr, Martin Law, et al.
Pharmaceutical Statistics|June 25, 2025
Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary EndpointsDominic Magirr, Craig Wang, Alexander Przybylski, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|February 14, 2012
Block response-adaptive randomization in clinical trials with binary endpointsDominic Magirr
Pharmaceutical Statistics|December 22, 2020
Non-proportional hazards in immuno-oncology: Is an old perspective needed?Dominic Magirr
Pharmaceutical Statistics|December 18, 2025
Robust Modestly Weighted Log-Rank TestsDominic Magirr, Fredrik Öhrn
Biometrical Journal. Biometrische Zeitschrift|February 3, 2023
Stratified modestly weighted log-rank tests in settings with an anticipated delayed separation of survival curvesDominic Magirr, José L Jiménez
JAMA Oncology|February 9, 2023
The MaxCombo Test Severely Violates the Type I Error RateDominic Magirr, Carl-Fredrik Burman
Statistics in Medicine|May 28, 2019
Modestly weighted logrank testsDominic Magirr, Carl-Fredrik Burman
Clinical Trials (London, England)|March 8, 2022
Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidanceDominic Magirr, José L Jiménez
Statistics in Medicine|December 24, 2015
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labelsMagdalena Żebrowska, Martin Posch, Dominic Magirr
Statistical Methods in Medical Research|December 18, 2012
Some recommendations for multi-arm multi-stage trialsJames Wason, Dominic Magirr, Martin Law, et al.
Pharmaceutical Statistics|June 25, 2025
Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary EndpointsDominic Magirr, Craig Wang, Alexander Przybylski, et al.
Pageof 2